Stock Events

Stock Events

Celon Pharma SA 

€4.43
4
+€0.11+2.67% Thursday 07:08

Statistics

Day High
4.31
Day Low
4.31
52W High
6.57
52W Low
4.29
Volume
-
Avg. Volume
-
Mkt Cap
237.39M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 24
€0.02
Jul 23
€0.02
Jul 22
€0.06
Aug 21
€0.02
Jun 20
€0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19NovExpected
Q1 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-16.64%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
96.72MRevenue
-16.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8RP.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical company that competes in various therapeutic areas similar to those targeted by Celon Pharma.
Novartis
NVS
Mkt Cap237.61B
Novartis AG is involved in the research, development, and marketing of pharmaceutical products, directly competing with Celon Pharma in multiple markets.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc operates in the pharmaceutical and healthcare sector, offering products that compete in the same categories as Celon Pharma.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a leading pharmaceutical company that develops medicines across many of the same fields as Celon Pharma.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC engages in the development of pharmaceutical products that directly compete with Celon Pharma's product line.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company offers a range of biopharmaceutical products, competing with Celon Pharma in several therapeutic areas.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates globally in the pharmaceutical sector, with a product range that overlaps with Celon Pharma's market interests.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. focuses on pharmaceuticals in areas like immunology and oncology, directly competing with Celon Pharma.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company develops and markets pharmaceutical products in areas that compete with Celon Pharma's focus.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries Limited manufactures generic and specialty medicines, competing with Celon Pharma in various therapeutic areas.

About

Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
Show more...
CEO
Dr. Maciej Wieczorek Ph.D.
Employees
568
Country
PL
ISIN
PLCLNPH00015
WKN
000A2DJW6

Listings

F
DE
8RP.F
WA
PL
CLN.WA
LSE
GB
0RKX.LSE

0 Comments

Share your thoughts

FAQ

What is Celon Pharma SA stock price today?▼
The current price of 8RP.F is €4.43 EUR — it has increased by +2.67% in the past 24 hours. Watch Celon Pharma SA stock price performance more closely on the chart.
What is Celon Pharma SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Celon Pharma SA stocks are traded under the ticker 8RP.F.
Is Celon Pharma SA stock price growing?▼
8RP.F stock has risen by +0.68% compared to the previous week, the month change is a -10.6% fall, over the last year Celon Pharma SA has showed a -27.73% decrease.
What is Celon Pharma SA market cap?▼
Today Celon Pharma SA has the market capitalization of 237.39M
What is Celon Pharma SA revenue for the last year?▼
Celon Pharma SA revenue for the last year amounts to 96.72M EUR.
What is Celon Pharma SA net income for the last year?▼
8RP.F net income for the last year is -16.09M EUR.
Does Celon Pharma SA pay dividends?▼
Yes, 8RP.F dividends are paid annual. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Celon Pharma SA have?▼
As of April 03, 2026, the company has 568 employees.
In which sector is Celon Pharma SA located?▼
Celon Pharma SA operates in the Health Care sector.
When did Celon Pharma SA complete a stock split?▼
Celon Pharma SA has not had any recent stock splits.
Where is Celon Pharma SA headquartered?▼
Celon Pharma SA is headquartered in Lomianki, PL.